Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
Inquirer on MSN1d
Ketamine a lifeline for severe depression patients in SingaporeKetamine, the controlled drug best known as a horse tranquilizer or party supplement, has in the last four years become a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback